ORIGINAL RESEARCH
Accepted on 27 Feb 2025
Efficacy and Safety of Tocilizumab in Managing Cytokine Release Syndrome After CD19 CAR-T Therapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
doi 10.3389/fimmu.2025.1530623
914
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: